Brief reportAn Atypical Presentation of Adenoid Cystic Carcinoma of the Lacrimal Gland
References (5)
- et al.
Adenoid cystic carcinoma developing in the nasal orbit
Am J Ophthalmol
(1997) - et al.
Adenoid cystic carcinoma of the lacrimal gland simulating a dermoid cyst in a 9-year-old boy
Arch Ophthalmol
(1998)
Cited by (27)
Adenoid cystic carcinoma of the orbit with bilateral cavernous sinus extension: A case report
2022, International Journal of Surgery Case ReportsCitation Excerpt :The diagnosis of ACC in these cases with the lack of the exact origin of the tumor in relation to the LG is challenging since these cases might have atypical clinical presentation. Tse and his coauthors reported ACC that presented initially as an orbital apex mass with cavernous sinus involvement and normal appearing ipsilateral LG [13]. Tumor origin in deep orbital ACC is uncertain.
Neoadjuvant Intra-Arterial Cytoreductive Chemotherapy for Lacrimal Gland Adenoid Cystic Carcinoma: A Long-Term Follow-up Study of a Trimodal Strategy
2022, American Journal of OphthalmologyCitation Excerpt :To illustrate the importance of assessing outcomes in the context of the patient group under treatment, the current series was compared with 2 contemporary globe-sparing surgery reports with sufficient raw data to abstract for K-M curve construction: PCSWo39 and PCSH.40 PCSWo reports a series of patients treated with proton beam therapy after conservative surgery.42 The Kaplan-Meier survival curves derived from the 2 reports appear similar to the IACC per-protocol (group 1).
Adenoid cystic carcinoma of the lacrimal gland: A case report
2022, Journal Francais d'OphtalmologieAtypical clinical presentation of an orbital cylindroma
2018, Journal Francais d'OphtalmologieAdenoid cystic carcinoma presenting as an orbital apex mass with intracranial extension
2016, Canadian Journal of OphthalmologyLong-term outcomes of neoadjuvant intra-arterial cytoreductive chemotherapy for lacrimal gland adenoid cystic carcinoma
2013, OphthalmologyCitation Excerpt :The residual disease served as a nidus to spawn tumor cells to the sinus mucosa probably by retrograde tracking along the lacrimal nerve toward the trunk of the ophthalmic nerve (V1) in the trigeminal ganglion. The tumor cells then crossed to the nasociliary nerve, a branch of V1 in the cavernous sinus, and tracked in an antegrade manner toward the anterior and posterior ethmoidal branches to involve the sinus mucosa.36 Completing all elements of the IACC protocol in a timely manner was important to the success of this treatment.
Supported in part by NIH center grant P30-EY014801; an unrestricted grant from Research to Prevent Blindness Inc, New York, New York; and a grant from the Plum Foundation, Los Angeles, California.
The authors, their families, their employers, and their business associates have no financial or proprietary interest in any product or company associated with any device, instrument, or drug mentioned in this article. The authors have not received any payment as consultants, reviewers, or evaluators of any of the devices, instruments, or drugs mentioned in this article.
This manuscript is based on a thesis that was prepared in partial fulfillment of the requirements for membership in the American Ophthalmological Society.